Dr. Prerana Jha

Senior Research Scientist

Dr. Prerana Jha, PhD in molecular oncology brings a vast experience of more than 15 years in the field of cancer research. She received her training at All India Institute of Medical Sciences, New Delhi and Comprehensive Cancer Center, Ohio State University, USA. She has a clear understanding of basic biology, advanced genomic techniques and has been continuously involved in implementation of continually upgrading technology in precision medicine. Her work has been recognized consistently through first author and several coauthor publications in high-impact oncology journals

Selected peer-reviewed publications

  1. Singh J*, Dandapath I*, Jha P*, et al. Gene expression-based profiling of pleomorphic xanthoastrocytoma highlights two prognostic subgroups. American Journal of translational Research. 2022 Feb 15;14(2):1010-1023. [* Equivalent authors]
  2. Dandapath* I, Gupta R*, Singh J, Shukla N, Jha P, Sharma V, Suri A, Sharma MC, Suri V, Sarkar C, Kulshreshtha R. Long non-coding RNA and mRNA co-expression network reveals novel players in pleomorphic xanthoastrocytoma. Mol Neurobiol. 2022 Jun 8.doi: 10.1007/s12035-022-02893-5. Online ahead of print.
  3. Manjunath N*, Jha P*, Singh J, Sarkar C, Mohan M, Mani K, Suri V. Clinico‑pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance? Neurol Sci 2020 Jul 14 [* Equivalent authors]
  4. Jha P, Manjunath N, Singh J, Garg A, Kaur K, Sharma MC, Suri A, Sarkar C, Suri V. Analysis of PDL1 expression and T cell infiltration in different molecular subgroups of diffuse midline gliomas. Neuropathology. 2019 Dec;39(6):413‑424.
  5. Kaur K, Jha P, Pathak P, Suri V, Sharma MC, Garg A, Suri A, Sarkar C. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in‑situ hybridization in resource constrained centres. J Neurooncol. 2019 Jul;143(3):393-403.